» Articles » PMID: 15304597

Progressive Myoclonus Epilepsy with Polyglucosans (Lafora Disease): Evidence for a Third Locus

Overview
Journal Neurology
Specialty Neurology
Date 2004 Aug 12
PMID 15304597
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Lafora disease (LD) is the most common teenage-onset progressive myoclonus epilepsy. It is caused by recessive mutations in the EPM2A or EPM2B genes. The authors describe a family with three affected members with no mutations in either gene. Linkage and haplotype analyses exclude both loci from causative involvement in this family. Therefore, a third LD locus is predicted. Its identification will be a crucial element in the understanding of the biochemical pathway underlying the generation of Lafora bodies and LD.

Citing Articles

ILAE Genetics Literacy series: Progressive myoclonus epilepsies.

Cameron J, Ellis C, Berkovic S Epileptic Disord. 2023; 25(5):670-680.

PMID: 37616028 PMC: 10947580. DOI: 10.1002/epd2.20152.


Lafora disease - from pathogenesis to treatment strategies.

Nitschke F, Ahonen S, Nitschke S, Mitra S, Minassian B Nat Rev Neurol. 2018; 14(10):606-617.

PMID: 30143794 PMC: 6317072. DOI: 10.1038/s41582-018-0057-0.


A recurrent homozygous variant in siblings with Lafora disease.

Araya N, Takahashi Y, Shimono M, Fukuda T, Kato M, Nakashima M Hum Genome Var. 2018; 5:16.

PMID: 30083360 PMC: 6043589. DOI: 10.1038/s41439-018-0015-9.


Lafora disease: from genotype to phenotype.

Parihar R, Rai A, Ganesh S J Genet. 2018; 97(3):611-624.

PMID: 30027899


Degradation of altered mitochondria by autophagy is impaired in Lafora disease.

Lahuerta M, Aguado C, Sanchez-Martin P, Sanz P, Knecht E FEBS J. 2018; 285(11):2071-2090.

PMID: 29645350 PMC: 5986609. DOI: 10.1111/febs.14468.